SCHEMBL17059586

SCHEMBL17059586

CCN(CC)C1CCN(c2ccc(N)c(OC)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 6/20 0.43
▸ LGMN Q99538 2/20 0.42
▸ EGFR P00533 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ CCR1 P32246 3/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ HTR4 Q13639 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13906256 0.86 LGMN (0.40) DPP4LGMNEGFRGAARAD52
SCHEMBL29661369 0.85 SUV39H2 (0.45) DPP4EGFRALDH1A1CYP3A4TSHR
SCHEMBL310055 0.85 SUV39H2 (0.45) DPP4EGFRALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL29367159 0.84 SUV39H2 (0.44) DPP4EGFRALDH1A1CYP3A4TSHR
SCHEMBL26484586 0.82 EGFR (0.40) DPP4EGFRALDH1A1CCR1DRD2
SCHEMBL17265199 0.82 ALDH1A1 (0.46) DPP4LGMNGAAALDH1A1CYP3A4
SCHEMBL10206172 0.81 ACVR1 (0.43) DPP4LGMNALDH1A1CYP3A4TSHR
SCHEMBL29989539 0.80 MEN1 (0.45) DPP4LGMNGAAALDH1A1CYP3A4
SCHEMBL517608 0.80 GAK (0.49) DPP4LGMNGAAALDH1A1CYP3A4
SCHEMBL520153 0.80 CCR4 (0.46) DPP4LGMNALDH1A1CCR1HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015127873-A1 ARYLAMINO PYRAMIDINE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM 上海海雁医药科技有限公司 2015-09-03 — — WO disclosed
Send feedback